MILPITAS, Calif., Nov. -- Palm, Inc. , and PHT Corp., the premier
provider of Electronic Patient Diaries (EPDs) for the collection
and management of clinical data, today announced that PHT has
purchased 4,650 Palm m515 handhelds. Mobile medical researchers
now can record observations for a clinical study on more than
21,000 bed-ridden deep vein thrombosis (DVT) patients using PHT's
solution running on the Palm m515 handheld. PHT has purchased
more than 17,000 Palm handhelds since December 2001.
Participating physicians and researchers who make house calls
to the DVT patients will use the Palm handhelds with PHT's solution,
called SitePad, to input critical medical data onsite. With this
portable solution, patient symptoms such as swelling and pain,
fever and rapid heart rates are captured, sorted and analyzed
in real time. Reactions to and effects of treatments are also
duly noted and saved. This mobile solution saves researchers time
and reduces errors associated with paper diaries, giving medical
research facilities accurate and attributable clinical trial data
in electronic form for regulatory approval.
PHT will supply clinical investigators with the SitePad solution,
which runs on the Palm m515 handheld. Observations and data are
entered directly into the SitePad at a patient's bedside. Once
investigators return to their offices and clinics, all captured
information is uploaded directly to the secure PHT Study Server
via a specially designed modem called the TeleCradle. Physicians
and researchers involved in the study can access the secure Study
Server to analyze the trial results in real time.
"Our clients conduct medical research that helps save human
lives, and Palm handhelds have become a trusted partner in this
process," said Linda Beneze, vice president, sales and marketing,
PHT Corp. "Palm handhelds provide a means to faster and more
accurate clinical results, and in the end, help the medical regulatory
community make more informed decisions."
DVT is a blood-clot condition caused by restricted blood flow
in the legs. An 11-hour flight from the United States to Europe
can be enough time for a painful blood clot to form. If not treated
properly, DVT can be life threatening. Together with PHT, Palm
handhelds help to speed the process of submitting trial results
for regulatory approval of effective treatments for DVT.
About PHT Corp.
PHT Corporation is the leading provider of mobile and Web-based
electronic data capture products for clinical trials. PHT enables
pharmaceutical companies to capture clinical trial data at the
point of experience. PHT's Product Suite enables dramatic improvement
in the quality and speed of data collected, thus increasing the
scientific value of the trial. The PHT Product Suite is built
on an open, flexible, and standards-based architecture to ensure
that the data collected can be integrated with and into other
clinical data management systems and processes. Our customers
include some of the leading pharmaceutical, biotechnology, and
medical technology companies around the globe. PHT is headquartered
in Charlestown, Massachusetts, with its European headquarters
in Geneva, Switzerland, and can be found on the Web at www.phtcorp.com.